Some judge will have the distinct honor of refereeing this fight for the rights to a controversial stem cell product. Who cares how many viable mesenchymal cells there are, its all about the benjamins. Will Orthofix be able to defend itself in a court of law to retain its right to sell Trinity, or will the Russian Bear look to take down another opponent? You know in some respects a leopard never changes his spots. Remember what TSB says, payback is a bitch. But when you make predictions to the street you must do anything to ascertain your objectives. The Street loves a confident and brash leader, yet still waters run deep. In all likelihood the chalk eaters will be betting NuVasive. Yet, as this case develops TSB can see someone hedging their bet based on the probability of a trial, but this could be a pick em. Lukianov could have fired off a teaser hoping to improve the point spread when he announced his intent to litigate with Orthofix.
TSB wants to know who do our readers believe is the "pup" in this event? Is it Orthofix? And if so, what are the potential scenarios that will develop. Will there be a KO? Will it be a TKO resulting in a revised licensing agreement? Or, will it be a draw? Never in a court of law. So does the "Beast from the East" have the stamina to float like a butterfly and sting like a bee, or, will it be the Primo Carnera of the spine world that throws the best punch? TSB wants to know what our readers think?